The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder

Trauma
Written By Rob Mudge, M.A.
MDMA To Treat Chronic & Treatment Resistant PTSD

Study

MDMA combined with pscyhotherapy to treat PTSD

Results

85% of participants showed significant decreases in PTSD symptoms, as opposed to 25% in the control group who received a placebo + therapy.

Discussion

MDMA could be effective in treating PTSD, especially those with chronic and treatment-resistant presentations.

Citation

Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of psychopharmacology (Oxford, England), 25(4), 439–452. doi:10.1177/0269881110378371

Link To Study

Rob Mudge, M.A.

Rob is a psychedelic therapist and integration coach who holds a Masters in Counseling Psychology from Boston College.

Previous

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers
Next

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy